These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37054948)
1. An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics. Borhani SG; Levine MZ; Krumpe LH; Wilson J; Henrich CJ; O'Keefe BR; Lo DC; Sittampalam GS; Godfrey AG; Lunsford RD; Mangalampalli V; Tao D; LeClair CA; Thole AP; Frey D; Swartz J; Rao G N Biotechnol; 2023 Sep; 76():13-22. PubMed ID: 37054948 [TBL] [Abstract][Full Text] [Related]
2. An approach to rapid distributed manufacturing of broad spectrum anti-viral griffithsin using cell-free systems to mitigate pandemics. Borhani SG; Levine MZ; Krumpe LH; Wilson J; Henrich CJ; Oâ Keefe BR; Lo D; Sittampalam GS; Godfrey AG; Lunsford RD; Mangalampalli V; Tao D; LeClair CA; Thole A; Frey D; Swartz J; Rao G bioRxiv; 2022 Dec; ():. PubMed ID: 36597541 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor. Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427 [TBL] [Abstract][Full Text] [Related]
4. Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent models. Barton C; Kouokam JC; Lasnik AB; Foreman O; Cambon A; Brock G; Montefiori DC; Vojdani F; McCormick AA; O'Keefe BR; Palmer KE Antimicrob Agents Chemother; 2014; 58(1):120-7. PubMed ID: 24145548 [TBL] [Abstract][Full Text] [Related]
6. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae. O'Keefe BR; Giomarelli B; Barnard DL; Shenoy SR; Chan PK; McMahon JB; Palmer KE; Barnett BW; Meyerholz DK; Wohlford-Lenane CL; McCray PB J Virol; 2010 Mar; 84(5):2511-21. PubMed ID: 20032190 [TBL] [Abstract][Full Text] [Related]
7. The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins. Bains A; Fischer K; Guan W; LiWang PJ Viruses; 2023 Dec; 15(12):. PubMed ID: 38140693 [TBL] [Abstract][Full Text] [Related]
8. Antiviral lectin Q-Griffithsin suppresses fungal infection in murine models of vaginal candidiasis. Nabeta HW; Lasnik AB; Fuqua JL; Wang L; Rohan LC; Palmer KE Front Cell Infect Microbiol; 2022; 12():976033. PubMed ID: 36329822 [TBL] [Abstract][Full Text] [Related]
9. Porcine deltacoronavirus infection is inhibited by Griffithsin in cell culture. Tang R; Guo L; Fan Q; Zhang L; Wang Y; Zhang X; Shi D; Wu Y; Shi H; Liu J; Chen J; Feng L Vet Microbiol; 2022 Jan; 264():109299. PubMed ID: 34896854 [TBL] [Abstract][Full Text] [Related]
10. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2. Patil AM; Göthert JR; Khairnar V Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930 [TBL] [Abstract][Full Text] [Related]
11. Novel Binding Mechanisms of Fusion Broad Range Anti-Infective Protein Ricin A Chain Mutant-Pokeweed Antiviral Protein 1 (RTAM-PAP1) against SARS-CoV-2 Key Proteins in Silico. Hassan Y; Ogg S; Ge H Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32957454 [TBL] [Abstract][Full Text] [Related]
12. Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks. Cao M; Su X; Jiang S Stem Cell Reports; 2021 Mar; 16(3):398-411. PubMed ID: 33691145 [TBL] [Abstract][Full Text] [Related]
13. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study]. Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014 [TBL] [Abstract][Full Text] [Related]
14. Stand Up to Stand Out: Natural Dietary Polyphenols Curcumin, Resveratrol, and Gossypol as Potential Therapeutic Candidates against Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Wang Z; Song XQ; Xu W; Lei S; Zhang H; Yang L Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764669 [TBL] [Abstract][Full Text] [Related]
15. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus. Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967 [TBL] [Abstract][Full Text] [Related]